Floatz logo

Neurotropin

Neuralgia

VanWorld Pharmaceutical (Rugao) Company LimitedPhase 3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
73/ 100

Competitive context

53 Active assets in the Neuralgia cohort.

Asset / SponsorPhaseRating
Bxcl501
Universidad Juárez Autónoma de Tabasco
Phase 4BBB
LIDOCAINE
Ataturk University
Phase 4BBB
MIDAZOLAM
Minia University
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Margaux M. Salas, PhD
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Medipol University
Phase 4BBB

View all 50 →

Same molecule, other indications

Neurotropin is also rated in:

complex regional pain syndrome type 1Dormant
CCC
Indicative ·
53 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
51 / 100
View asset →
complex regional pain syndrome type 2Dormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →